GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 24251 - 24300 of 40384 in total
PDB ID UniProt ID Title ▲ Descriptor
7V84 7V84 Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V84 Q9BYF1 Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V84 7V84 Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 P0DTC2 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 Q9BYF1 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 7V87 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 Q9BYF1 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 7V87 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
8G78 P0DTC2 Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD
8G78 8G78 Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD
8DPZ P0DTC2 Local refinement of SARS-CoV-2 vaccine induced antibody DH1338 bound to SARS-CoV-2 HexaPro RBD Spike ectodomain
8DPZ 8DPZ Local refinement of SARS-CoV-2 vaccine induced antibody DH1338 bound to SARS-CoV-2 HexaPro RBD Spike ectodomain
8CT3 P02724 Local refinement of band3-I transmembrane region from class 2 of erythrocyte ankyrin-1 complex
8CT3 P02730 Local refinement of band3-I transmembrane region from class 2 of erythrocyte ankyrin-1 complex
7U0D A0A7U3CI26 Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodies B-182.1 and A19-46.1
7U0D 7U0D Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodies B-182.1 and A19-46.1
8R9X 8R9X Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
8HED P0DTC2 Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab
8HED 8HED Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab
7Q4E P12821 Local refinement structure of a single N-domain of full-length, dimeric, soluble somatic angiotensin I-converting enzyme
7Q4C P12821 Local refinement structure of the C-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme
7Q49 P12821 Local refinement structure of the N-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme
7Q4D P12821 Local refinement structure of the two interacting N-domains of full-length, dimeric, soluble somatic angiotensin I-converting enzyme
7WRZ 7WRZ Local resolution of BD55-5840 Fab and SARS-COV2 Omicron RBD
7WRZ P0DTC2 Local resolution of BD55-5840 Fab and SARS-COV2 Omicron RBD
7WSC 7WSC Local structure of BD55-3500 and omicron RBD complex
7WSC P0DTC2 Local structure of BD55-3500 and omicron RBD complex
7WRY 7WRY Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex
7WRY P0DTC2 Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex
7Y0W 7Y0W Local structure of BD55-5514 and BD55-5840 Fab and Omicron BA.1 RBD complex
7Y0W P0DTC2 Local structure of BD55-5514 and BD55-5840 Fab and Omicron BA.1 RBD complex
8Y7Y Q5MQD0 Local structure of HCoV-HKU1A spike in complex with TMPRSS2 and glycan
8Y7Y O15393 Local structure of HCoV-HKU1A spike in complex with TMPRSS2 and glycan
8Y8B Q0ZME7 Local structure of HCoV-HKU1C spike in complex with TMPRSS2 and glycan
8Y8B O15393 Local structure of HCoV-HKU1C spike in complex with TMPRSS2 and glycan
8Y8J Q0ZME7 Local structure of HCoV-HKU1C spike in complex with glycan
5NET Q6PMW3 Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.
5NET Q80B23 Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.
5NET E1ACS1 Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.
5NET P06756 Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.
5NET P18564 Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.
5NER A0A1P8NWT0 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NER A0A1B0SZV3 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NER J3T9N5 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NER A6Y878 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NER P06756 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NER P18564 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.
5NEM A0A1B0SZV3 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A.
5NEM J3T9N5 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A.
5NEM A6Y878 Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A.

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024